- Staat
- FL
- Alter
- 72,0
- Geschlecht
- M
- Eingang
- 12.11.2022
- Impfdatum
- 06.10.2022
- Beginn
- 07.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Inflammation
Pain in extremity
Symptomtext
left and right arm inflamed, pain in hands and joints
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- montelukast celebrex
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 02.11.2022
- Impfdatum
- 13.10.2022
- Beginn
- 13.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Headache
Incorrect dose administered
Product administered to patient of inappropriate age
Symptomtext
61-year-old patient was given a high dose flu vaccine dose instead of a regular flu dose vaccine. Patient stated that they had a severe headache for approximately one day that improved with rest and staying hydrated with water.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 30.10.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site rash
Injection site warmth
Symptomtext
The patient had a warm red rash under the injection site. Patient's son is a physician and called in a prescription for Bactrim DS for possible cellulitis
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- prostate cancer
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 17.10.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ataxia
Hyperhidrosis
Pain
Urinary incontinence
Vomiting
Symptomtext
Patient reported having loss of control of arms, legs, and bladder, vomiting, sweats and generalized pain that began about 2 hours after having the vaccine and lasted about 14 hours after. Did not contact our office until 10/12/22 and did not seek treatment at ER.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- None, did not seek treatment at PCP or ER
- Aktuelle Erkrankungen
- Hypertension, diabetes type 2 and elevated creatinine.
- Vorgeschichte
- Hypertension, diabetes type 2, depression, hyperlipidemia,
- Andere Medikamente
- glimepiride 2 mg 1 tablet by mouth twice daily Amlodipine 10 mg 1 tablet by mouth daily Vitamin B 12 injection inject 1 milliliter by intramuscular route monthly Hydrochlorothiazide 50 mg, 1 table by mouth daily Lantus inject 50 units by su
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 09.05.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Symptomtext
This patient might of received a 2nd flu dose this flu season.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 09.05.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
This patient might of received a 2nd flu dose this flu season.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 09.05.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
This patient might of received a 2nd flu dose this flu season.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 09.05.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
This patient might of received a 2nd flu vaccine this flu season.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 09.05.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Symptomtext
This patient might of received a 2nd flu vaccine this flu season.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 09.05.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Patient received a dose of the Fluzone HD which is for patients 65 and older and they were only 62 at the time of the dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 20.03.2023
- Impfdatum
- 17.03.2023
- Beginn
- 17.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
Patient DID NOT have an adverse. Patient got a high dose instead of low dose vaccine. Patient was called and notified, patient states she has been doing fine and did not even have soreness at injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- Lexapro 10mg, Aspirin 81mg, Estradiol 1mg
- Allergien
- KNA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 26.12.2022
- Impfdatum
- 15.09.2022
- Beginn
- 15.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient given Fluzone High Dose indicated for 65 and older. Patient is 59 yo.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 23.12.2022
- Impfdatum
- 22.09.2022
- Beginn
- 22.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient was given high dose flu vaccine under the age of 65. Patient had no concerns or side effects
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 30.11.2022
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Incorrect product formulation administered
Product administered to patient of inappropriate age
Symptomtext
Client was inadvertently given High Dose Fluzone instead of Fluzone Quadrivalent.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 22.11.2022
- Impfdatum
- 20.09.2022
- Beginn
- 07.11.2022
- Tage bis Beginn
- 48,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
While clerk was going thru billing it was found that this patient had received 2 High Dose Flu Vaccines. One dose of the high dose flu vaccine was given at off site location during flu out reach on 09/20/2022 and the other dose was given in the clinic on 11/07/2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- Unknown
- Allergien
- no known drug allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 12.11.2022
- Impfdatum
- 06.10.2022
- Beginn
- 07.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Drainage
Laboratory test
Loss of personal independence in daily activities
Musculoskeletal disorder
Peripheral swelling
Symptomtext
Patient's right arm swelled up so large she could not use her hand to write or for daily function/activity; was admitted to the hospital for 6 days; fluid removed, antibiotics and steroids given and tests/exams run
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Drainage
- Hospital-Tage
- 6,0
- Labordaten
- unkown
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- xalatan ibandronate omeprazole xanax
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 10.11.2022
- Impfdatum
- 09.11.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Administered influenza and bivalent covid vaccines to patient on 10/14/22 at senior living facility. In error, the same vaccines were administered to patient again on 11/9/22. Describe the adverse event(s), treatment, and outcome(s), if any: (symptoms, signs, time course, etc.) Administered influenza and bivalent covid vaccines to patient on 10/14/22 at senior living facility during a Covid/Flu vaccine clinic for residents and employees. Facility requested a second Covid/Flu vaccine clinic for more residents and employees. On 11/9/22, our pharmacy went to administer vaccines and in error, the patient was received a repeated Influenza and bivalent covid vaccine (in <1 month). Alerted Director of Nursing at facility and patient's physician when error was discovered (11/9/22).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Calcium antacid 500mg, Escitalopram 10mg, Lorazepam 0.5mg, Prescriptions, OTC meds, dietary supplements being taken at the time of vaccination continued: Melatonin 5mg, Senior Women Multivitamin, Trazodone 50mg, Vitamin D3 2000 IU, Acetami
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.11.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
administered the FLUZONE HIGH-DOSE QIV to 9 employees that are under the age of 65 with no reported adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case is linked to cases 2022SA447057(CLUSTER), 2022SA446385(CLUSTER) and 2022SA448075(CLUSTER). This case involves Adult and unknown gender patient who was administered the fluzone high-dose qiv who was under the age of 65 with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (formulation, strength and dose not reported; lot UT7729CA) via unknown route in unknown administration site for prophylactic vaccination. On an unknown date, the the fluzone high-dose qiv was administered to 9 employees that are under the age of 65 with no reported adverse event (product administered to patient of inappropriate age) (latency: same day) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: related FLUZONE HD QIV CASE 01340119: related FLUZONE HD QIV CASE 01340226: related FLUZONE HD QIV CASE 01340229: related FLUZONE HD QIV CASE 01340234: related FLUZONE HD QIV CASE 01340240: related FLUZONE HD QIV CASE 01340243: related FLUZONE HD QIV CASE 01340302: related FLUZONE HD QIV CASE 01340314:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
employees that were under the age of 65 were administered fluzone hd qiv instead of the fluzone qiv with no reported adverse event; employees that were under the age of 65 were administered fluzone hd qiv instead of the fluzone qiv with no reported adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a physician. This case is linked to cases 2022SA446068, 2022SA446195, 2022SA446385, 2022SA447853, 2022SA447822, 2022SA448075, 2022SA447385 and 2022SA448121. This case involves a 62 years old female patient who was administered Quadrival A-B high dose hv vaccine [Fluzone high-dose quadrivalent] instead of the Fluzone QIV with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 04-Oct-2022, the patient received 0.7 ml dose once of suspect Quadrival A-B high dose hv vaccine (lot UT7729CA, exp date: 30-Jun-2022) via intramuscular route in the right deltoid for Immunization at inappropriate age instead of the Fluzone QIV with no reported adverse event (product administered to patient of inappropriate age) (wrong product administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 08.11.2022
- Impfdatum
- 18.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case is linked to cases 2022SA447057(CLUSTER), 2022SA446385(CLUSTER) and 2022SA448075(CLUSTER). This case involves a 54 years old male patient was under the age of 65 were administered influenza quadrival A-B high dose HV vaccine [fluzone high-dose quadrivalent] instead of the fluzone QIV with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 18-Oct-2022, the patient received suspect influenza quadrival A-B high dose HV vaccine at a dose of 0.7 ml once (lot UT7729CA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 18-Oct-2022, the patient who was under the age of 65 were administered fluzone hd qiv instead of the fluzone qiv with no adverse event (wrong product administered, product administered to patient of inappropriate age, latency: same day). Action taken: Not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 08.11.2022
- Impfdatum
- 19.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
administered FLUZONE HD QIV instead of the FLUZONE QIV with no reported adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case is linked to cases 2022SA447057(CLUSTER) and 2022SA446385(CLUSTER). This case involves a 39 years old male patient who was administered fluzone hd qiv (vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE) instead of the fluzone qiv with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 19-Oct-2022, the patient received a dose of 0.7 ml of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (formulation, strength: unknown) lot UT7729CA, Expiration date: 30-Jun-2023, via intramuscular route in the left deltoid as Immunization. On 19-OCT-2022 the patient was administered fluzone hd qiv instead of the fluzone qiv with no reported adverse event (wrong product administered) same day following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
patient that was under the age of 65 being administered FLUZONE HIGH DOSE QIV instead of the FLUZONE QIV at a flu clinic with no reported adverse event; patient that was under the age of 65 being administered FLUZONE HIGH DOSE QIV instead of the FLUZONE QIV at a flu clinic with no reported adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case from a consumer/non-hcp. This case is linked to cases 2022SA447057(CLUSTER), 2022SA446385(CLUSTER), 2022SA446068(CLUSTER), 2022SA447385(CLUSTER), 2022SA447853(CLUSTER), 2022SA446195(CLUSTER), 2022SA447822(CLUSTER) and 2022SA448121(CLUSTER). This case involves a 62 years old female patient who was under the age of 65 being administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] instead of the fluzone qiv at a flu clinic with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 04-Oct-2022, the patient received suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE at a dose of 0.7 ml total once(lot UT7729CA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 04-Oct-2022 the patient under the age of 65 being administered fluzone high dose qiv instead of the fluzone qiv at a flu clinic with no reported adverse event (wrong product administered, product administered to patient of inappropriate age, latency: same day) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Action taken: Not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 03.11.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional. This case is linked to cases 2022SA447057(CLUSTER) and 2022SA446385(CLUSTER). This case involves a 35 years old male patient who was under the age of 65 were administered influenza quadrival A-B high dose HV vaccine [fluzone high-dose quadrivalent] instead of the fluzone QIV with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 04-Oct-2022, the patient received suspect influenza quadrival A-B high dose HV vaccine at a dose of 0.7 ml (lot UT7729CA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 04-Oct-2022, the patient who was under the age of 65 were administered fluzone hd qiv instead of the fluzone qiv with no adverse event (wrong product administered, product administered to patient of inappropriate age, latency: same day). Action taken: Not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional This case is linked to cases 2022SA447057(CLUSTER), 2022SA446385(CLUSTER) and 2022SA448075(CLUSTER). This case involves a 22 years old female patient who was under the age of 65 were administered influenza quadrival A-B high dose HV vaccine [fluzone high-dose quadrivalent] instead of the fluzone QIV with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 15-Oct-2022, the patient received suspect influenza quadrival A-B high dose HV vaccine at a total dose of 0.7 ml once (lot UT7729CA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 15-Oct-2022, the patient who was under the age of 65 were administered fluzone hd qiv instead of the fluzone qiv with no adverse event (wrong product administered, product administered to patient of inappropriate age, latency: same day). Action taken: Not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
administered FLUZONE HD QIV instead of the FLUZONE QIV. with no reported adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case is linked to cases 2022SA447057(CLUSTER), 2022SA446385(CLUSTER) and 2022SA448075(CLUSTER). This case involves a 23 years old female patient who was administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] instead of the INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 15-Oct-2022 the patient developed a non-serious event of administered fluzone hd qiv (dose: 0.7ml, 1X(once), intramuscularly in left deltoid, batch number: UT7729CA and expiry date: 30-Jun-2023 for Immunization) instead of the fluzone qiv. with no reported adverse event (wrong product administered) (Latency: same day). Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 18.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; under the age of 65 were administered FLUZONE HD QIV instead of the FLUZONE QIV with no adverse event; Initial information received on 26-Oct-2022 regarding an unsolicited valid non-serious case from a consumer/non-hcp. This case is linked to cases 2022SA446068(CLUSTER), 2022SA447057(CLUSTER), 2022SA447385(CLUSTER), 2022SA447853(CLUSTER), 2022SA448075(CLUSTER), 2022SA446195(CLUSTER), 2022SA447822(CLUSTER), 2022SA448121(CLUSTER) and 2022SA447057(CLUSTER). This case involves a 59 years old female patient who was under the age of 65 were administered influenza quadrival A-B high dose HV vaccine [fluzone high-dose quadrivalent] instead of the fluzone QIV with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 18-Oct-2022, the patient received suspect influenza quadrival A-B high dose HV vaccine at a dose of 0.7 ml (lot UT7729CA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 18-Oct-2022 the patient developed a non-serious under the age of 65 were administered fluzone hd qiv instead of the fluzone qiv with no adverse event (wrong product administered, product administered to patient of inappropriate age, latency: same day). Action taken: Not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
High Dose Fluzone vaccine administered to patient under age 65.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- DM Type 2
- Andere Medikamente
- atenolol, Synjardy, escitalopram, alendronate, chlordiazepoxide, gabapentin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 92,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient came in and requested to get his flu shot. Flu shot was processed and administered. Patient then mentioned that he received his Covid vaccine 2 weeks ago but the info was not filled out on vaccine card and asked me to up date his card. I reviewed his file and he had actually received his flu shot on 9/20/22 and not his Covid vaccine. I informed patient and asked him to let us know if he experience any side effects/adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 30.09.2022
- Impfdatum
- 26.09.2022
- Beginn
- 26.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
27 years patient received FLUZONE HD with no reported adverse event; Initial information received on 26-Sep-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 27 years old male patient who received vaccine influenza quadrival a-b high dose hv vaccine [Fluzone High-Dose Quadrivalent] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Sep-2022, the patient had received a dose of 0.7 mL total of suspect influenza quadrival a-b high dose hv vaccine (lot number-UT7729CA, expiry date- 30-Jun-2023) (with an unknown strength, formulation) via intramuscular route in the arm NOS (not otherwise specified) for Immunization. On 26-Sep-2022, (latency same day) the patient developed a non-serious event 27 years old patient had received fluzone HD with no reported adverse event (product administered to patient of inappropriate age) following the administration of influenza quadrival a-b high dose hv vaccine. No lab data was reported Action taken with quadrivalent influenza vaccine was not applicable. At time of reporting, the outcome was Unknown for the event 27 years patient received fluzone HD with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -